Overview

HCV Post-Exposure Prophylaxis for Health Care Workers

Status:
Withdrawn
Trial end date:
2020-01-16
Target enrollment:
Participant gender:
Summary
This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore needles.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Gilead Sciences
Treatments:
Sofosbuvir
Velpatasvir